Skip to main content

Faculty | Fellowship Program

Clinical Faculty:

Dr Lee

Dr. Eugene K. Lee (Program Director)

  • Urothelial Cancer - Radical Cystectomy (Conduit and Neobladder), Nephroureterectomy, Ureterectomy
  • Prostate Cancer - RALP
  • Kidney Cancer - Nephrectomy (Radical, Partial, Open, Robotic, Laparoscopic)
  • Testicular Cancer - Radical Orchiectomy and RPLND
  • Penile Cancer - Penectomy and Inguinal lymphadenectomy
Dr Duchene

Dr. David A. Duchene 

  • Kidney Cancer - Nephrectomy (Radical, Partial, Open, Robotic, Laparoscopic)
  • Urothelial Cancer - Nephroureterectomy, Ureterectomy
  • Prostate Cancer
Dr Holzbeierlein

Dr. Jeffrey M. Holzbeierlein 

  • Bladder Cancer - Radical Cystectomy (Conduit and Neobladder, Open and Robotic)
  • Kidney Cancer - Nephrectomy (Radical, Partial, Open, Robotic, Laparoscopic)
  • Testicular Cancer - Radical Orchiectomy and RPLND
  • Penile Cancer - Penectomy and Inguinal lymphadenectomy
Dr Mirza

Dr. Moben Mirza 

  • Urothelial Cancer - Radical Cystectomy (Conduit and Neobladder), Nephroureterectomy, Ureterectomy
  • Prostate Cancer - RALP
  • Kidney Cancer - Nephrectomy (Radical, Partial, Open, Robotic, Laparoscopic)
  • Testicular Cancer - Radical Orchiectomy and RPLND
  • Penile Cancer - Penectomy and Inguinal lymphadenectomy
Dr Taylor

Dr. John A. Taylor III

  • Urothelial Cancer - Radical Cystectomy (Conduit and Neobladder), Nephroureterectomy, Ureterectomy
Dr Thrasher

Dr. J. Brantley Thrasher

  • Prostate Cancer - Prostatectomy (Robotic, Retropubic, Perineal)
Dr Wyre

Dr. Hadley W. Wyre

  • Reconstructive Oncology - Post-radiation oncology
  • Reconstructive Urology - parastomal hernia repair, post-radical cystectomy ureteral stricture repair
  • Urothelial Cancer - Radical Cystectomy (Conduit and Neobladder), Nephroureterectomy, Ureterectomy
  • Kidney Cancer - Nephrectomy (Radical, Partial, Open, Robotic, Laparoscopic)
  • Testicular Cancer - Radical Orchiectomy and RPLND
  • Penile Cancer - Penectomy and Inguinal lymphadenectomy

Dr. Mehmood Hashmi 

  • GU Medical Oncology

Dr. Xinglei Shen 

  • GU Radiation Oncology

Research Faculty: Basic and Translational Science Laboratories

Dr Li Benyi Li is an MD/PhD, who focuses on signal transduction in prostate cancer. His areas of focus include the GSK3-beta pathway and inhibitors of this pathway. He has three full time post-docs in his laboratory and two research assistants. He has funding from several foundations and extramural sources. He coordinates the basic science laboratories in the Department of Urology.
Dr Holzbeierlein Jeffrey M. Holzbeierlein, MD is a surgeon-scientist. His laboratory focuses on the production and development of HSP90 inhibitors in prostate and bladder cancer. Dr. Holzbeierlein has a long track record of basic/translational science publications and is currently funded through an NIH R01. He also sits in the John Weigel Chair of Urology which helps support the basic science efforts of the Urology Department.
Dr Lee Eugene K. Lee, MD, Assistant Professor of Urology, has a translational laboratory focusing on glucose metabolism in bladder cancer. He is the PI of two bladder cancer related investigator initiated clinical trials developed through laboratory-based concepts. Dr. Lee is currently funded through a 2-year Urology Care Foundation Research Award, an American Cancer Society Institutional Research Grant, and a University of Kansas Cancer Center Pilot Grant. 
Dr Taylor John Taylor, III, MD is an accomplished surgeon-scientist. He recently relocated from the University of Connecticut where he served as the Founder and Director of the Leo and Anne Albert Institute for Bladder Cancer Care and Research. Dr. Taylor has published extensively in the field of biomarkers and chemoresistance in bladder cancer. He is also an expert at mouse models in bladder cancer. Dr. Taylor is well known within the bladder cancer community and brings a team of researchers from the University of Connecticut to the University of Kansas Medical Center.

Clinical Research Faculty:

Jill Hamilton-Reeves, PhD is a dietician 100% dedicated to clinical and translational research.  Her interests focus on nutrition and lifestyle modification in Prostate Cancer survivors and in Prevention.  In addition, she works with bladder cancer patients on preventing weight loss after cystectomy and with immunonutrition at the time of radical cystectomy.  She correlates outcomes with bio and immune markers in her laboratory. Dr. Hamilton-Reeves is funded through a KL2 Scholar Award through the NIH National Center for Advancing Translational Science and a Frontier's Pilot Award.
Shellie Ellis, PhD is an expert in Health Policy & Management. She uses qualitative and quantitative research methodologies to improve the quality of cancer care delivery. Her main area of interest is in disparities in prostate cancer treatment, adoption of new technologies, and reimbursement issues in treatment decisions. 
Devon Koestler, PhD is a biostatistician with a specific interest in urologic research. He has years of experience working with large datasets and the development of cancer specific nomograms. Past projects and grants involve working with the New Hampshire tumor registry containing demographic information on 7,000 patients with superficial bladder cancer including 800 subjects with methylation data.
Last modified: Sep 28, 2018
ID=x27808